New Prostate Cancer Treatments 2022

Last updated: 13 November 2023

New Prostate Cancer Treatments 2022

You can legally access new medicines, even if they are not approved in your country.

Learn how

What is Prostate Cancer?

Prostate cancer is the most common cancer among men (after skin cancer). The prostate is a gland that is only found in men. It is responsible for making some of the fluid that nourishes and transports sperm. Many prostate cancers grow slowly and do not grow outside of the prostate gland. They will need minimal or even no treatment. However, some types grow much faster and can quickly grow outside of the prostate (advanced) or spread to other parts of the body (metastasized).1


Prostate Cancer symptoms

Early prostate cancer usually does not cause any symptoms. More advanced prostate cancers sometimes cause symptoms, including:

  • Problems urinating, such as a weak or interrupted stream, increased frequency, difficulty emptying the bladder
  • Blood in the urine or semen
  • Trouble getting an erection (erectile dysfunction)
  • Pain in the hips, back, chest, or other areas when the cancer has metastasized to bones

Note: these symptoms may be caused by conditions other than prostate cancer.


Treatment of Prostate Cancer

There are different treatment options for prostate cancer. Together with your doctor you will decide what is the best prostate cancer treatment for you. Treatment usually includes surgery and radiation therapy for prostate cancer. Other options include chemotherapy and hormone treatment for prostate cancer, which both aim to kill the cancer cells.


Prostate Cancer treatment side effects

It is helpful to learn more about the side effects of treatment upfront, so you know what to expect. Your treating prostate physician can discuss this with you and help you manage your wellbeing during and after treatment. Not everyone reacts the same to treatment and people experience side effects differently. Always talk to your healthcare professional about any adverse reactions you may be experiencing, such as erectile dysfunction, pain, nausea, tiredness, incontinence and bodily changes that affect your sense of self.


What are the newest Prostate Cancer Treatments?

There are several approved Prostate Cancer treatments options. Here are some of them:


Orgovyx (relugolix)

Orgovyx (relugolix) is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for treating prostate cancer in advanced stages. It is the first oral prostate cancer treatment option available for men with advanced disease.

Orgovyx (relugolix) was approved for the treatment of adults with advanced prostate cancer by:

  • The Food and Drug Administration (FDA), USA, on December 18, 2020

Erleada (apalutamide)

Erleada (apalutamide) is indicated to treat men with non-metastatic castration-resistant prostate cancer (NM-CRPC) who no longer respond to medical or surgical hormone treatment that lowers testosterone.

Erleada (apalutamide) was approved for NM-CRPC by:

  • Food and Drug Administration (FDA), USA, in February 2018
  • Health Canada, Canada, in July 2018
  • Therapeutic Goods Administration (TGA), Australia, in July 2018, under the brand name Erlyand.
  • European Medicine Agency (EMA), EU, in January 2019

Nubeqa (darolutamide)

Nubeqa (darolutamide) is a medication used to treat men with non-metastatic castration-resistant prostate cancer (NM-CRPC).

Nubeqa (darolutamide) was approved for NM-CRPC by:

  • Food and Drug Administration (FDA), USA, in February 2018
  • Health Canada, Canada, in July 2018
  • Therapeutic Goods Administration (TGA), Australia, in July 2018, under the brand name Erlyand.
  • European Medicine Agency (EMA), EU, in March 2020

If you are trying to access Prostate Cancer drugs that are approved outside of your country of residence, we might be able to help you access it with the support of your treating doctor. You can read more about the medicines we can help you and your doctor access and about their price below:




Why access and buy treatments for Prostate Cancer with everyone.org?

everyone.org is registered in The Hague with the Dutch Ministry of Health as a pharmaceutical wholesale distributor (registration number 16258 G). We have helped patients from over 85 countries to access thousands of medicines that are not yet approved in their home country, including patients suffering from Prostate Cancer. With a prescription from your treating doctor, you can count on our expert team to safely and legally guide you to access Prostate Cancer drugs in your country. If you or someone you know are looking to access a medicine that is not yet approved where you live, we will support you. Contact us for more information.


References:

  1. Prostate Cancer
  2. Orgovyx (relugolix) - Thesocialmedwork.com
  3. Orgovyx product information sheet [PDF]
  4. Nubeqa (darolutamide) - Thesocialmedwork.com
  5. Nubeqa product information sheet [PDF]
  6. Erleada (apalutamide) - Thesocialmedwork.com
  7. Erleade product information sheet [PDF]

Disclaimer: This article is not meant to influence or impact the care provided by your treating physician. Please do not make changes to your treatment without first consulting your healthcare provider. This article is not intended to diagnose or treat illness or to influence treatment decisions. everyone.org is as diligent as possible in compiling and updating the information on this page. However, everyone.org does not guarantee the correctness and completeness of the information provided on this page.